Patients with prolonged or chronic cough
Conditions
Interventions
H1 blocker or ICS/LABA
Sponsors
Third Department of Internal Medicine, FAculty of Medical Sciences, University of Fukui
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients whose cough comtinues more than 3 weeks
Exclusion criteria
Exclusion criteria: Patients with apparent productive cough Respiratory infection required abtibiotics Abnormal chest X-ray causing cough Patients who do not consent to the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect of H1 blocker or combination of ICS and LABA on cough as a primary therapy | — |
Countries
Japan
Contacts
Public ContactTamotsu Ishizuka
Faculty of Medical Sciences, University of Fukui Third Department of Internal Medicine
Outcome results
None listed